Integrated Health Systems wants to partner with your practice. We are interested in clinics specializing in regenerative, sports, and anti-aging medicine. We offer several gene therapies meant to systematically address an array of health issues by tackling the aging process itself at its root cause.
Telomeres are one of the hottest topics in aging research right now, and for good reason. Our telomerase gene therapy can restore telomere length. Follistatin, a myostatin inhibitor, fights sarcopenia – one of the major contributors of age-related frailty and Metabolic Syndrome.
Even the most active of people begin losing muscle mass as they grow older and that’s why follistatin has obvious benefits for physically active people, from professional athletes to casual fitness enthusiasts looking to stay in shape through their golden years. The most exercise can do is slow sarcopenia down.
Our eighth patient states, “I can feel my muscles are stronger and recover faster after exercise. I also like that my scans show that they are less fatty than before treatment.”
Telomerase, as mentioned before, has a positive effect on bone strength. Klotho is more strongly correlated to IQ than any known gene. Telomerase also has a beneficial effect on motor function and cognitive performance. Both of these are essential to success on and off the field.
Anything that shaves off recovery time, helps burn fat, and improve muscle strength, has obvious and far-reaching applications in athletics.
Beauty comes from the inside. We believe this is true because there’s compelling evidence for it. That’s why cosmetic surgeons may be intrigued by the potential of follistatin and telomerase gene therapies.
Besides helping people feel better, telomerase and follistatin can help them look better too. In 2005 Flores, Blasco, and Cayuela linked telomerase activation to the mobilization of stem cells. Skin cells treated with telomerase reverse transcriptase replicated 40 more times than the control groups and exhibited more youthful gene expression profiles.
Blasco, Maria A. “Telomeres and human disease: ageing, cancer and beyond.” Nature Reviews Genetics 6.8 (2005): 611.
Boukamp, Petra. “Skin aging: a role for telomerase and telomere dynamics?.” Current molecular medicine 5.2 (2005): 171-177.
Cameron, Brent, and Gary E. Landreth. “Inflammation, microglia, and Alzheimer’s disease.” Neurobiology of disease 37.3 (2010): 503-509.
Cawthon, Richard M., et al. “Association between telomere length in blood and mortality in people aged 60 years or older.” The Lancet 361.9355 (2003): 393-395.
Cawthon, Richard. “Methods of predicting mortality risk by determining telomere length.” U.S. Patent No. 9,169,516. 27 Oct. 2015.
Dubal, Dena B., et al. “Life extension factor klotho enhances cognition.” Cell reports 7.4 (2014): 1065-1076.
Flores, Ignacio, María L. Cayuela, and María A. Blasco. “Effects of telomerase and telomere length on epidermal stem cell behavior.” Science 309.5738 (2005): 1253-1256.
Hu, Ming Chang, Makoto Kuro-o, and Orson W. Moe. “Klotho and chronic kidney disease.” Phosphate and Vitamin D in Chronic Kidney Disease. Vol. 180. Karger Publishers, 2013. 47-63.
Kim, Ji-Hee, et al. “Biological role of anti-aging protein Klotho.” Journal of lifestyle medicine 5.1 (2015): 1.
Kim, Tae Nyun, et al. “Skeletal muscle mass to visceral fat area ratio is associated with metabolic syndrome and arterial stiffness: the Korean Sarcopenic Obesity Study (KSOS).” Diabetes research and clinical practice 93.2 (2011): 285-291.
Morley, John E., et al. “Sarcopenia.” Journal of Laboratory and Clinical Medicine 137.4 (2001): 231-243.
Yamamoto, Masaya, et al. “Regulation of oxidative stress by the anti-aging hormone klotho.” Journal of Biological Chemistry 280.45 (2005): 38029-38034.